BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ozcan A, Shen SS, Zhai QJ, Truong LD. Expression of GLUT1 in primary renal tumors: morphologic and biologic implications. Am J Clin Pathol 2007;128:245-54. [PMID: 17638658 DOI: 10.1309/HV6NJVRQKK4QHM9F] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Yamasaki T, Seki N, Yoshino H, Itesako T, Yamada Y, Tatarano S, Hidaka H, Yonezawa T, Nakagawa M, Enokida H. Tumor-suppressive microRNA-1291 directly regulates glucose transporter 1 in renal cell carcinoma. Cancer Sci. 2013;104:1411-1419. [PMID: 23889809 DOI: 10.1111/cas.12240] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 5.9] [Reference Citation Analysis]
2 Sinha S, Mondal G, Hwang EJ, Han da W, Dutta SK, Iyer S, Karumanchi SA, Kim KI, Couch FJ, Mukhopadhyay D. Von Hippel-Lindau gene product directs cytokinesis: a new tumor suppressor function. J Cell Sci 2011;124:2132-42. [PMID: 21652636 DOI: 10.1242/jcs.087122] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
3 Sanders E, Diehl S. Analysis and interpretation of transcriptomic data obtained from extended Warburg effect genes in patients with clear cell renal cell carcinoma. Oncoscience 2015;2:151-86. [PMID: 25859558 DOI: 10.18632/oncoscience.128] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
4 Ogorevc M, Strikic A, Tomas SZ. Determining the immunohistochemical expression of GLUT1 in renal cell carcinoma using the HSCORE method. Biomed Rep 2021;15:79. [PMID: 34429965 DOI: 10.3892/br.2021.1455] [Reference Citation Analysis]
5 Sędzikowska A, Szablewski L. Human Glucose Transporters in Renal Glucose Homeostasis. Int J Mol Sci 2021;22:13522. [PMID: 34948317 DOI: 10.3390/ijms222413522] [Reference Citation Analysis]
6 Wu Y, Wei X, Feng H, Hu B, Liu B, Luan Y, Ruan Y, Liu X, Liu Z, Wang S, Liu J, Wang T. An eleven metabolic gene signature-based prognostic model for clear cell renal cell carcinoma. Aging (Albany NY) 2020;12:23165-86. [PMID: 33221754 DOI: 10.18632/aging.104088] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Airley R, Evans A, Mobasheri A, Hewitt SM. Glucose transporter Glut-1 is detectable in peri-necrotic regions in many human tumor types but not normal tissues: Study using tissue microarrays. Ann Anat 2010;192:133-8. [PMID: 20395120 DOI: 10.1016/j.aanat.2010.03.001] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.7] [Reference Citation Analysis]
8 Ritterson Lew C, Guin S, Theodorescu D. Targeting glycogen metabolism in bladder cancer. Nat Rev Urol 2015;12:383-91. [PMID: 26032551 DOI: 10.1038/nrurol.2015.111] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 5.0] [Reference Citation Analysis]
9 Pinthus JH, Whelan KF, Gallino D, Lu JP, Rothschild N. Metabolic features of clear-cell renal cell carcinoma: mechanisms and clinical implications. Can Urol Assoc J. 2011;5:274-282. [PMID: 21801687 DOI: 10.5489/cuaj.10196] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 3.6] [Reference Citation Analysis]
10 Cho SY, Szabo Z. Molecular imaging of urogenital diseases. Semin Nucl Med 2014;44:93-109. [PMID: 24484747 DOI: 10.1053/j.semnuclmed.2013.10.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
11 Chakraborty S, Balan M, Sabarwal A, Choueiri TK, Pal S. Metabolic reprogramming in renal cancer: Events of a metabolic disease. Biochim Biophys Acta Rev Cancer 2021;1876:188559. [PMID: 33965513 DOI: 10.1016/j.bbcan.2021.188559] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Ambrosetti D, Dufies M, Dadone B, Durand M, Borchiellini D, Amiel J, Pouyssegur J, Rioux-Leclercq N, Pages G, Burel-Vandenbos F, Mazure NM. The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma. PLoS One 2018;13:e0193477. [PMID: 29481555 DOI: 10.1371/journal.pone.0193477] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
13 Calvo MB, Figueroa A, Pulido EG, Campelo RG, Aparicio LA. Potential role of sugar transporters in cancer and their relationship with anticancer therapy. Int J Endocrinol. 2010;2010. [PMID: 20706540 DOI: 10.1155/2010/205357] [Cited by in Crossref: 93] [Cited by in F6Publishing: 95] [Article Influence: 7.8] [Reference Citation Analysis]
14 da Cunha JP, Galante PA, de Souza JE, Pieprzyk M, Carraro DM, Old LJ, Camargo AA, de Souza SJ. The human cell surfaceome of breast tumors. Biomed Res Int 2013;2013:976816. [PMID: 24195083 DOI: 10.1155/2013/976816] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
15 Kobayashi M, Uematsu T, Tokura Y, Takei K, Sakamoto K, Narimatsu T, Nukui A, Kamai T. Immunohistochemical expressionof sodium-dependent glucose transporter - 2 (SGLT-2) in clear cell renal carcinoma: possible prognostic implications. Int Braz J Urol 2019;45:169-78. [PMID: 30521176 DOI: 10.1590/S1677-5538.IBJU.2018.0271] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
16 Wettersten HI, Aboud OA, Lara PN Jr, Weiss RH. Metabolic reprogramming in clear cell renal cell carcinoma. Nat Rev Nephrol 2017;13:410-9. [PMID: 28480903 DOI: 10.1038/nrneph.2017.59] [Cited by in Crossref: 108] [Cited by in F6Publishing: 109] [Article Influence: 21.6] [Reference Citation Analysis]
17 Szablewski L. Distribution of glucose transporters in renal diseases. J Biomed Sci 2017;24:64. [PMID: 28854935 DOI: 10.1186/s12929-017-0371-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
18 Pragallapati S, Manyam R. Glucose transporter 1 in health and disease. J Oral Maxillofac Pathol 2019;23:443-9. [PMID: 31942129 DOI: 10.4103/jomfp.JOMFP_22_18] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]